Search research articles
Contact Us
Filters
Showing results (41-50 of 258) with videos related to
Page
of 26
Sort By:
Journal of Pharmaceutical Sciences
|
December 1, 1984
Controlled long-term release of small peptide hormones using a new microporous polypropylene polymer: its application for vasopressin in the Brattleboro rat and potential perinatal use
J Kruisbrink, G J Boer
European Journal of Morphology
|
January 1, 1990
Developmental and functional aspects of grafting of the suprachiasmatic nucleus in the Brattleboro and the arrhythmic rat
G J Boer, H A Griffioen
Journal of the American Academy of Dermatology
|
January 28, 1999
Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa
J Boer, M J van Gemert
Clinical and Experimental Dermatology
|
June 25, 2009
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa
J Boer, G B E Jemec
Journal of Developmental Physiology
|
April 1, 1983
Neuropeptides and brain development. Current perils and future potential
D F Swaab, G J Boer
Neurobehavioral Toxicology and Teratology
|
May 1, 1986
Vasopressin and vasopressin-antagonists applied to neonatal Wistar rats: effects on body and brain development and water metabolism
F G Snijdewint, G J Boer
Neurochemistry International
|
May 22, 2010
Disorders of cell acquisition in the brain of rats deficient in vasopressin (Brattleboro mutant)
G J Boer, A J Patel
The Journal of Nutrition
|
March 19, 2010
The growth promoting action of vaccenic acid
J BOER, B C P JANSEN
Peptides
|
January 1, 1985
Neuropeptide effects on brain development to be expected from behavioral teratology
G J Boer, D F Swaab
Neurotoxicology and Teratology
|
July 1, 1988
Neonatal treatment with vasopressin antagonist dP[Tyr(Me)2]AVP, but not with vasopressin antagonist d(CH2)5[Tyr(Me)2]AVP, inhibits body and brain development and induces polyuria in the rat
F G Snijdewint, G J Boer
Page
of 26
Search research articles
Search
Showing results (41-50 of 258) with videos related to
Sort By:
Page
of 26
Journal of Pharmaceutical Sciences
|
December 1, 1984
Controlled long-term release of small peptide hormones using a new microporous polypropylene polymer: its application for vasopressin in the Brattleboro rat and potential perinatal use
J Kruisbrink, G J Boer
European Journal of Morphology
|
January 1, 1990
Developmental and functional aspects of grafting of the suprachiasmatic nucleus in the Brattleboro and the arrhythmic rat
G J Boer, H A Griffioen
Journal of the American Academy of Dermatology
|
January 28, 1999
Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa
J Boer, M J van Gemert
Clinical and Experimental Dermatology
|
June 25, 2009
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa
J Boer, G B E Jemec
Journal of Developmental Physiology
|
April 1, 1983
Neuropeptides and brain development. Current perils and future potential
D F Swaab, G J Boer
Neurobehavioral Toxicology and Teratology
|
May 1, 1986
Vasopressin and vasopressin-antagonists applied to neonatal Wistar rats: effects on body and brain development and water metabolism
F G Snijdewint, G J Boer
Neurochemistry International
|
May 22, 2010
Disorders of cell acquisition in the brain of rats deficient in vasopressin (Brattleboro mutant)
G J Boer, A J Patel
The Journal of Nutrition
|
March 19, 2010
The growth promoting action of vaccenic acid
J BOER, B C P JANSEN
Peptides
|
January 1, 1985
Neuropeptide effects on brain development to be expected from behavioral teratology
G J Boer, D F Swaab
Neurotoxicology and Teratology
|
July 1, 1988
Neonatal treatment with vasopressin antagonist dP[Tyr(Me)2]AVP, but not with vasopressin antagonist d(CH2)5[Tyr(Me)2]AVP, inhibits body and brain development and induces polyuria in the rat
F G Snijdewint, G J Boer
Page
of 26